Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.58 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 2/20 | 0.39 |
| ▸ | TGM2 | P21980 | 3/20 | 0.39 |
| ▸ | CBLB | Q13191 | 4/20 | 0.38 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.37 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL17105877 | 0.98 | ZDHHC20 (0.56) | ZDHHC20ZDHHC2KMT2AATMTSHR | |
| Water SCHEMBL2355003 | 0.98 | ZDHHC20 (0.56) | ZDHHC20ZDHHC2KMT2AATMTSHR | |
| Hydrochloric Acid SCHEMBL26669425 | 0.98 | ZDHHC20 (0.56) | ZDHHC20ZDHHC2KMT2AATMTSHR | |
| Iodide SCHEMBL2254575 | 0.98 | ZDHHC20 (0.56) | ZDHHC20ZDHHC2KMT2AATMTSHR | |
| Bromide SCHEMBL475865 | 0.98 | ZDHHC20 (0.56) | ZDHHC20ZDHHC2KMT2AATMTSHR | |
| Fluoride Ion SCHEMBL17105892 | 0.98 | ZDHHC20 (0.56) | ZDHHC20ZDHHC2KMT2AATMTSHR | |
| Hydrochloric Acid SCHEMBL127417 | 0.98 | ZDHHC20 (0.56) | ZDHHC20ZDHHC2KMT2AATMTSHR | |
| Hydrochloric Acid SCHEMBL3405400 | 0.98 | ZDHHC20 (0.56) | ZDHHC20ZDHHC2KMT2AATMTSHR | |
| Hydrochloric Acid SCHEMBL31470991 | 0.96 | ZDHHC20 (0.55) | ZDHHC20ZDHHC2KMT2AATMTSHR | |
| Chloromethane SCHEMBL27393558 | 0.96 | ZDHHC20 (0.55) | ZDHHC20ZDHHC2KMT2AATMTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1952 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4048747-B1 | SELF-STOPPING POLISHING COMPOSITION AND METHOD | CMC MAT LLC (US) | 2026-02-18 | — | — | EP | claimed |
| US-20260028770-A1 | SURFACE MODIFIED MICROCAPSULES | INT FLAVORS & FRAGRANCES INC (US) | 2026-01-29 | — | — | US | claimed |
| US-12531244-B2 | Polymer coating process for electrode assemblies incorporating ion exchange materials | ZELOS ENERGY LTD. (US) | 2026-01-20 | — | — | US | claimed |
| EP-3784707-B1 | STABLE POLYUREA MICROCAPSULE COMPOSITIONS | INT FLAVORS & FRAGRANCES INC (US) | 2025-12-24 | — | — | EP | claimed |
| US-12491494-B2 | Moisture swing CO2 sorbents with enhanced capacity and kinetics | Genesee Valley Innovations, LLC (US) | 2025-12-09 | — | — | US | claimed |
| US-20250360088-A1 | CHARGE MODIFIED CHITOSAN CROSS-LINKED ENCAPSULATE | ENCAPSYS, LLC (US) | 2025-11-27 | — | — | US | claimed |
| US-12454791-B2 | Surface modified microcapsules | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2025-10-28 | — | — | US | claimed |
| EP-4627036-A1 | CHARGE MODIFIED CHITOSAN CROSS-LINKED ENCAPSULATE | Encapsys, LLC (US) | 2025-10-08 | — | — | EP | claimed |
| EP-4531798-B1 | METHOD OF PRODUCING BIODEGRADABLE MICROCAPSULES | UNILEVER IP HOLDINGS B V (NL) | 2025-09-24 | — | — | EP | claimed |
| EP-3578588-B1 | HIGH EFFICIENCY WET STRENGTH RESINS FROM NEW CROSS-LINKERS | ECOLAB USA INC (US) | 2025-07-02 | — | — | EP | claimed |
| EP-1014999-A1 | CATIONIC POLYMERS AS TOXIN-BINDING AGENTS | GELTEX PHARMACEUTICALS, INC. (US) | 2000-07-05 | — | — | EP | claimed |
| EP-0915705-A1 | IONIC POLYMERS AS ANTI-INFECTIVE AGENTS | GELTEX PHARMACEUTICALS, INC. (US) | 1999-05-19 | — | — | EP | claimed |
| WO-1999015186-A1 | CATIONIC POLYMERS AS TOXIN-BINDING AGENTS | GELTEX PHARMACEUTICALS, INC. (US) | 1999-04-01 | — | — | WO | claimed |
| EP-0560519-B1 | Use of water-soluble polymers in cleaning compositions, and water-soluble polymers for such use | ROHM & HAAS (US) | 1998-08-05 | — | — | EP | claimed |
| WO-1997049413-A1 | IONIC POLYMERS AS ANTI-INFECTIVE AGENTS | GELTEX PHARMACEUTICALS, INC. (US) | 1997-12-31 | — | — | WO | claimed |
| EP-0282093-B1 | AQUEOUS SUSPENSION OF DELAMINATED VERMICULITE | HERCULES INCORPORATED (US) | 1991-11-13 | — | — | EP | claimed |
| US-4877551-A | Aqueous suspension of delaminated vermiculite | HERCULES INCORPORATED (US) | 1989-10-31 | — | — | US | claimed |
| EP-0282093-A2 | Aqueous suspension of delaminated vermiculite | HERCULES INCORPORATED (US) | 1988-09-14 | — | — | EP | claimed |
| EP-0139588-B1 | AMPHOLYTIC CATIONIC TETRAPOLYMERS, THEIR USE IN THE TREATMENT OF KERATIN FIBRES AND COMPOSITIONS CONTAINING THEM | SOCIETE FRANCAISE HOECHST Société anonyme dite: (FR) | 1987-07-01 | — | — | EP | claimed |
| EP-0139588-A2 | Ampholytic cationic tetrapolymers, their use in the treatment of keratin fibres and compositions containing them | SOCIETE FRANCAISE HOECHST Société anonyme dite: (FR) | 1985-05-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028770-A1 | SURFACE MODIFIED MICROCAPSULES | CHRM5, TAS2R45, TAS2R42 | ZDHHC20 1344/4885ZDHHC2 2450/4885KMT2A 3276/4885 |
| US-12531244-B2 | Polymer coating process for electrode assemblies incorporating ion exchange materials | NCSTN, GNE, NCS1 | ZDHHC20 3951/4885ZDHHC2 3362/4885KMT2A 4094/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.